ExodusPoint Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,870
| Closed | -$1.15M | – | 1776 |
|
|
2024
Q4 | $1.15M | Buy |
+29,870
| New | +$1.15M | 0.01% | 827 |
|
|
2023
Q4 | – | Sell |
-177,125
| Closed | -$2.95M | – | 1866 |
|
|
2023
Q3 | $2.95M | Buy |
177,125
+162,471
| +1,109% | +$2.71M | 0.03% | 510 |
|
|
2023
Q2 | $405K | Buy |
+14,654
| New | +$405K | ﹤0.01% | 1338 |
|
|
2023
Q1 | – | Sell |
-90,107
| Closed | -$983K | – | 1959 |
|
|
2022
Q4 | $983K | Sell |
90,107
-18,769
| -17% | -$205K | 0.01% | 929 |
|
|
2022
Q3 | $918K | Sell |
108,876
-2,250
| -2% | -$19K | 0.01% | 1114 |
|
|
2022
Q2 | $879K | Buy |
+111,126
| New | +$879K | 0.01% | 1095 |
|
|
2021
Q1 | – | Sell |
-15,701
| Closed | -$317K | – | 2439 |
|
|
2020
Q4 | $317K | Buy |
+15,701
| New | +$317K | ﹤0.01% | 1446 |
|
|
2019
Q2 | – | Sell |
-30,119
| Closed | -$379K | – | 1261 |
|
|
2019
Q1 | $379K | Buy |
30,119
+15,919
| +112% | +$200K | 0.03% | 395 |
|
|
2018
Q4 | $96K | Buy |
+14,200
| New | +$96K | 0.01% | 305 |
|